Biomedicines . 2020 Jun 11;8(6):E157. doi: 10.3390/biomedicines8060157.

Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation After MI in Mice

Nicole Zarniko  ¹ , Anna Skorska  ^{1   2} , Gustav Steinhoff  ^{1   2} , Robert David  ^{1   2} , Ralf Gaebel  ^{1   2}

Abstract

Several cell populations derived from bone marrow (BM) have been shown to possess cardiac regenerative potential. Among these are freshly isolated CD133⁺ hematopoietic as well as culture-expanded mesenchymal stem cells. Alternatively, by purifying CD271⁺ cells from BM, mesenchymal progenitors can be enriched without an ex vivo cultivation. With regard to the limited available number of freshly isolated BM-derived stem cells, the effect of the dosage on the therapeutic efficiency is of particular interest. Therefore, in the present pre-clinical study, we investigated human BM-derived CD133⁺ and CD271⁺ stem cells for their cardiac regenerative potential three weeks post-myocardial infarction (MI) in a dose-dependent manner. The improvement of the hemodynamic function as well as cardiac remodeling showed no therapeutic difference after the transplantation of both 100,000 and 500,000 stem cells. Therefore, beneficial stem cell transplantation post-MI is widely independent of the cell dose and detrimental stem cell amplification in vitro can likely be avoided.